tiprankstipranks
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN

Compare Newron Pharmaceuticals SpA (NWRN) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
CHF15.04
CHF309.59M
-9.69
141.80%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF136.47M
-2.50
9.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF664.04M
16.63
36.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.52
CHF891.34M
-8.17
253.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF16.64
CHF236.25M
-0.98
25.49%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.50
CHF124.00M
3.99
13.16%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:NWRN
Newron Pharmaceuticals SpA
15.04
8.55
131.74%
CH:MOLN
Molecular Partners AG
3.38
0.17
5.30%
CH:BSLN
Basilea Pharmaceutica
54.50
13.45
32.76%
CH:IDIA
Idorsia Ltd
3.52
2.47
233.71%
CH:SANN
Santhera Pharmaceuticals Holding
16.64
3.08
22.71%
CH:XLS
Xlife Sciences Ltd.
21.50
2.30
11.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts